Verrica Pharmaceuticals (VRCA)

• Market cap: $96.4M
• 1 day: -1.31%
• 5 days: 5.6%
• 1 month: 9.44%
• 3 months: -29.88%
• 6 months: 36.73%
• Year to date: -27.35%
• 1 year: -7.37%
• 5 years: -96.38%
• 10 years: -96.55%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71